Kenya Launches Pfizer’s Accord for a Healthier World to Expand Affordable Access to Medicines and Vaccines
Thursday, June26, 2025 – 4:00am
The Kenya Ministry of Health and Pfizer have launched Accord for a Healthier World in Kenya to enable access to the full portfolio of medicines and vaccines for which Pfizer has global rights on a not-for-profit basis in the public health system.
The Accord, launched in 2022, aims to provide access to essential health solutions for 1.2 billion people in 45 lower-income countries. The initiative also supports these countries in addressing system-level barriers to healthcare access, such as strengthening supply chains, advancing medical education, and pursuing efficient regulatory pathways.
“This partnership with Pfizer under the Accord for a Healthier World is a timely boost to our national agenda for Universal Health Coverage. It will expand access to quality, life-saving medicines and vaccines for millions of Kenyans, particularly in underserved areas,” said Dr. Ouma Oluga, Principal Secretary for Medical Services. “Beyond improving availability, this collaboration will strengthen local capacity, address systemic access barriers, and align with our long-term vision of a resilient, inclusive and equitable health system for all.”
Through the Accord, Kenya Medical Supplies Agency (KEMSA), the medical logistics provider for the MoH’s public health facilities and programs, will be able to procure Pfizer’s full portfolio of medicines and vaccines for which it has global rights—both current and future products, priced on a not-for-profit basis to support national healthcare goals. This includes a portfolio of hundreds of essential, medicines and vaccines - around 40% of which are in the World Health Organization’s (WHO) list of essential medicines - as well as breakthrough prevention and treatment options for many of the most significant infectious and non-communicable diseases. Additionally, Pfizer and the MoH will begin collaboration to identify and address system-level barriers that limit or prevent patients from accessing treatments they need, when they need them.
“Everyone, no matter where they live or their income level, should have access to the medicines and vaccines they need. Yet a tremendous health equity gap exists that determines who can access those innovations and who cannot” said Nick Lagunowich, Global President Emerging Markets, Pfizer. “Through the Accord, we’re committed to not just enabling product supply, but to collaborating with country governments to help make sure that treatments can reach patients in need, now and in the future. We look forward to working with the Kenya Ministry of Health to create meaningful and sustainable impact for patients.”
To date, Pfizer has framework agreements in place with 14 Accord-eligible countries, 13 of which are in Africa, and is in advanced negotiations with several more. In 2024, products supplied through the initiative reached more than 200,000 patients in eligible lower-income countries. In collaboration with country governments, the Accord has also supported efforts to reach thousands across healthcare systems in eligible countries with capability and capacity building support.
Cabinet Secretary Honorable Adan Duale and Nick Lagunowich, Global President Emerging Markets, Pfizer at the Kenya-Accord launch ceremony